Key facts
- This page summarizes Yan Zhang's Form 4 filing for Evofem Biosciences, Inc. (EVFM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2024, 17:13.
Yan Zhang - 12 Jan 2024 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2024, 17:13:24 UTC
- Prior SEC filing
- 26 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ivy Zhang
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Yan Zhang filed Form 4 for Evofem Biosciences, Inc. (EVFM) on 12 Jan 2024.
Change
- Previous filing in this sequence was filed on 26 Apr 2023.
- Current net transaction value: -$4.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EVFM
transaction
Common Stock
Sale
- Transaction value
- $4
- Shares
- -104
- Change %
- -100%
- Price
- $0.0385
- Shares after
- 0
- Date
- 12 Jan 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.